You simply are looking for funding buying a stock, although purchasing ones appropriate stock on right occasion without having a plan looks incredibly frustrating. A few of the Nifty Pharma Index stock costs move incredibly fast and is actually backed by stronger fundamentally and/or technically uptrend. It’s time in order to assess compelling stocks showing signs concerning energy than the remainder market. There are no shortcuts inside choosing one ideal stock without worrying about gaining understanding. Your precise strategy for finding great stock is actually with ones analytical skills which try created among continuous understanding. Here’s on updated a number of Nifty Pharma stocks of 2022.
You may have actually heard regarding exclusively two big stock exchanges inside India – Bombay stock exchange (BSE) then National stock exchange (NSE). Some sort of NSE (National Stock Exchange of India Ltd) try all youngest stock exchange out of India created in will year 1992 with the Securities and Exchange Board of India (SEBI) guidelines then rules. It is the biggest and commonly traded stock exchange at India. In India, NSE had been 1st trade towards implement paperless payment then advance electronic investing techniques concerning investors. NSDL (National Securities Depository Limited) offers advanced security inside investors to people of holding, dealing plus moving his or her paperless securities seamlessly. NSE has a fully integrated business model comprising change listings, indices, clearing and/or settlement services, investing services, market information feeds, financial education additionally technologies options. Calculation of Nifty Pharma holdings was represented considering on free float market capitalization stocks weightage.
List of Nifty Pharma Index Stocks of 2022
Indian stock market consist of above 6,500+ stocks which is really a genuine question using this theory. It is difficult doing fundamental analysis of all stocks occasionally. Right here you can use your stock screener in order to very first shortlist few great stocks after NSE Nifty Pharma stocks. You can subsequently get-ahead towards check out their technical chart concerning deep analysis.
Name Of Company | Exchange | Sector | FV | Market Cap (Cr) | EPS | P/E Ratio | Intrinsic Value | Book Value | 1-Yr Return | 3-Yrs Return | 5-Yrs Return | 10-Yrs Return | 52 Week High | 52 Week Low | 1-Yr Dividend | 3-Yrs Dividend | Abbott India Limited | NSE & BSE | Pharmaceuticals | ₹10.00 | ₹45,797.04 | 332.29 | 64.86 | ₹5,588.35% | ₹1,224.59 | 34.43% | 43.5% | 35.34% | 30.86% | ₹23,934.45 | ₹13,959.80 | 84.61% | 68.29% | Alembic Pharmaceuticals Limited | NSE & BSE | Pharmaceuticals | ₹2.00 | ₹15,854.78 | 52.97 | 15.23 | ₹1,043.35% | ₹260.86 | -16.09% | 9.95% | 3.63% | 33.21% | ₹1,145.00 | ₹720.35 | 23.36% | 21.28% | Alkem Laboratories Limited | NSE & BSE | Pharmaceuticals | ₹2.00 | ₹46,543.07 | 136.42 | 28.53 | ₹2,028.86% | ₹616.96 | 46.86% | 25.25% | 17.37% | ₹4,070.00 | ₹2,540.05 | 22.63% | 24.77% | Aurobindo Pharma Limited | NSE & BSE | Pharmaceuticals | ₹1.00 | ₹42,606.53 | 90.87 | 8.0 | ₹1,155.22% | ₹374.27 | -9.81% | -1.3% | -2.73% | 27.77% | ₹1,063.90 | ₹660.30 | 4.39% | 5.59% | Biocon Limited | NSE & BSE | Biotechnology | ₹5.00 | ₹41,738.86 | 5.63 | 62.6 | ₹105.19% | ₹63.53 | -22.38% | 2.99% | 16.65% | 19.64% | ₹487.75 | ₹327.55 | 0.0 | 2.21% | Cadila Healthcare Limited | NSE & BSE | Pharmaceuticals | ₹1.00 | ₹55,701.83 | 22.14 | 24.02 | ₹255.67% | ₹126.91 | 26.42% | 12.95% | 6.64% | 13.66% | ₹673.70 | ₹404.00 | 16.8% | 22.21% | Cipla Limited | NSE & BSE | Pharmaceuticals | ₹2.00 | ₹73,514.38 | 31.52 | 28.92 | ₹288.56% | ₹227.19 | 16.49% | 12.48% | 8.98% | 12.18% | ₹1,005.00 | ₹706.50 | 16.77% | 17.81% | Divi’s Laboratories Limited | NSE & BSE | Pharmaceuticals | ₹2.00 | ₹1,42,613.70 | 77.2 | 69.59 | ₹1,122.07% | ₹350.12 | 66.7% | 60.42% | 33.23% | 30.91% | ₹5,332.65 | ₹3,015.00 | 26.76% | 29.67% | Dr. Reddy’s Laboratories Limited | NSE & BSE | Pharmaceuticals | ₹5.00 | ₹82,512.28 | 104.47 | 47.49 | ₹1,401.24% | ₹1,072.03 | -2.4% | 24.57% | 10.24% | 12.54% | ₹5,614.60 | ₹4,135.00 | 21.32% | 19.62% | Glenmark Pharmaceuticals Limited | NSE & BSE | Pharmaceuticals | ₹1.00 | ₹14,808.18 | 36.24 | 14.63 | ₹458.55% | ₹250.37 | 6.91% | -4.35% | -10.95% | 6.21% | ₹690.95 | ₹442.05 | 7.27% | 7.49% | Granules India Limited | NSE & BSE | Pharmaceuticals | ₹1.00 | ₹8,144.51 | 22.54 | 14.59 | ₹359.82% | ₹87.63 | -15.28% | 51.68% | 21.82% | 47.71% | ₹437.95 | ₹295.00 | 6.76% | 8.36% | IPCA Laboratories Limited | NSE & BSE | Pharmaceuticals | ₹2.00 | ₹30,726.12 | 78.87 | 30.71 | ₹1,217.32% | ₹370.64 | 14.73% | 53.34% | 31.34% | 25.7% | ₹2,766.20 | ₹1,785.40 | 8.9% | 9.28% | Laurus Labs Limited | NSE & BSE | Pharmaceuticals | ₹2.00 | ₹34,932.82 | 19.63 | 33.17 | ₹202.22% | ₹48.32 | 99.63% | 100.89% | ₹723.75 | ₹252.00 | 10.91% | 12.8% | Lupin Limited | NSE & BSE | Pharmaceuticals | ₹2.00 | ₹42,971.71 | 36.42 | 26.01 | ₹355.83% | ₹304.01 | -9.03% | 1.82% | -8.57% | 7.25% | ₹1,267.65 | ₹855.35 | 24.24% | -13.12% | Natco Pharma Limited | NSE & BSE | Pharmaceuticals | ₹2.00 | ₹16,225.33 | 21.57 | 41.28 | ₹378.67% | ₹226.04 | -0.09% | 7.44% | 8.25% | 34.8% | ₹1,189.00 | ₹771.50 | 21.73% | 22.03% | Pfizer Limited | NSE & BSE | Pharmaceuticals | ₹10.00 | ₹25,333.26 | 125.27 | 44.21 | ₹1,180.84% | ₹523.10 | 11.33% | 24.57% | 24.02% | 14.99% | ₹6,175.00 | ₹4,330.00 | 32.18% | 117.57% | Strides Pharma Science Limited | NSE & BSE | Pharmaceuticals | ₹10.00 | ₹5,320.66 | -4.48 | 110.28 | -20.4 | ₹309.28 | -20.4% | 10.97% | -9.49% | 4.69% | ₹999.00 | ₹562.55 | 8.35% | 120.41% | Sun Pharmaceutical Industries Limited | NSE & BSE | Pharmaceuticals | ₹1.00 | ₹2,01,856.05 | 25.02 | 35.2 | ₹342.88% | ₹193.65 | 72.79% | 12.34% | 2.5% | 13.16% | ₹846.80 | ₹452.25 | 61.97% | 37.4% | Torrent Pharmaceuticals Limited | NSE & BSE | Pharmaceuticals | ₹5.00 | ₹52,972.63 | 74.52 | 42.01 | ₹626.63% | ₹344.94 | 14.07% | 26.11% | 13.75% | 26.83% | ₹3,250.20 | ₹2,311.10 | 47.32% | 55.37% |
---|
Examples of Nifty Pharma Stocks/Companies
Let us assume that 10 years back you have purchased Biocon Limited (BIOCON) from Healthcare (Biotechnology & Drugs) sector. In 10 years, Biocon Ltd stock has rise with 21% Compound annual growth rate (CAGR). Suppose you have invested ₹3,80,000 principal in Biocon Limited (BIOCON) stock. Calculate 10 years returns with CAGR formula for Biocon Ltd stock. Your investment value will be ₹25,56,450 in 10 years.
Conclusion
This conclude the List of Nifty Pharma Index Stocks of 2022. The examples of NSE Nifty Pharma Index Stock will help you to take effective investment decisions. Happy Reading!
Read More
- List of Nifty Oil Gas Index Stocks of 2022
- List of Nifty Next 50 Index Stocks of 2022
- List of Nifty MNC Index Stocks of 2022
- List of Nifty Mid Smallcap 400 Index Stocks of 2022
- List of Nifty Midcap 50 Index Stocks of 2022
[wpcode id=”11768″]